Published On: Thu, Sep 14th, 2017

Reviewing Individual Broker Targets Of Agilent Technologies, Inc. (NYSE:A)


Recently stock market analysts have updated their consensus ratings on shares of Agilent Technologies, Inc. (NYSE:A).

Most recent broker ratings

08/23/2017 – Agilent Technologies, Inc. had its “buy” rating reiterated by analysts at Deutsche Bank. They now have a USD 70 price target on the stock.

08/16/2017 – Agilent Technologies, Inc. had its “buy” rating reiterated by analysts at Jefferies. They now have a USD 70 price target on the stock.

07/13/2017 – Agilent Technologies, Inc. was upgraded to “outperform” by analysts at Wells Fargo.

07/10/2017 – Agilent Technologies, Inc. had its “overweight” rating reiterated by analysts at Morgan Stanley. They now have a USD 75 price target on the stock.

05/23/2017 – Agilent Technologies, Inc. had its “buy” rating reiterated by analysts at BTIG Research. They now have a USD 65 price target on the stock.

05/23/2017 – Agilent Technologies, Inc. had its “outperform” rating reiterated by analysts at Robert W. Baird. They now have a USD 62 price target on the stock.

05/23/2017 – Agilent Technologies, Inc. had its “market perform” rating reiterated by analysts at Cowen. They now have a USD 62 price target on the stock.

02/15/2017 – Agilent Technologies, Inc. had its “neutral” rating reiterated by analysts at UBS. They now have a USD 50 price target on the stock.

01/04/2017 – Agilent Technologies, Inc. was upgraded to “overweight” by analysts at Barclays. They now have a USD 51 price target on the stock.

12/21/2016 – Agilent Technologies, Inc. had its “buy” rating reiterated by analysts at Janney Montgomery Scott. They now have a USD 10 price target on the stock.

11/10/2016 – Leerink Swann began new coverage on Agilent Technologies, Inc. giving the company a “outperform” rating. They now have a USD 53 price target on the stock.

09/07/2016 – Agilent Technologies, Inc. had its “buy” rating reiterated by analysts at Goldman Sachs. They now have a USD 53 price target on the stock.

08/18/2016 – Agilent Technologies, Inc. had its “buy” rating reiterated by analysts at Evercore ISI. They now have a USD 53 price target on the stock.

02/17/2016 – Agilent Technologies, Inc. had its “equal-weight” rating reiterated by analysts at Bank of America Merrill Lynch. They now have a USD 42 price target on the stock.

10/15/2015 – Agilent Technologies, Inc. had its “neutral” rating reiterated by analysts at Citigroup. They now have a USD 40 price target on the stock.

Agilent Technologies, Inc. has a 50 day moving average of 61.91 and a 200 day moving average of 57.80. The stock’s market capitalization is 21.06B, it has a 52-week low of 42.92 and a 52-week high of 66.42.

The share price of the company (NYSE:A) was down -1.06% during the last trading session, with a high of 66.22 and the volume of Agilent Technologies, Inc. shares traded was 2042563.

Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.